Formation, characterization and pH dependence of rifampicin: heptakis(2,6-di-O-methyl)-β-cyclodextrin complexes.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International journal of pharmaceutics

• Publication date

  2017-10-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2017.06.015PMID 28596140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inclusion complexes of 2-methoxyestradiol with dimethylated and permethylated β-cyclodextrins: models for cyclodextrin–steroid interaction

  2015cited by this paper
• Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin.

  2014cited by this paper
• Resistance to rifampicin: a review

  2014cited by this paper
• Molecular encapsulation of rifampicin as an inclusion complex of hydroxypropyl-β-cyclodextrin: design; characterization and in vitro dissolution.

  2013cited by this paper
• Benefits of methylated cyclodextrins in the development of midazolam pharmaceutical formulations.

  2013cited by this paper
• Intramolecular proton transfer impact on antibacterial properties of ansamycin antibiotic rifampicin and its new amino analogues.

  2012cited by this paper
• Encapsulation of rifampicin by natural and modified β-cyclodextrins: characterization and thermodynamic parameters

  2010cited by this paper
• Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.

  2010cited by this paper
• Acid Resistance in Mycobacterium tuberculosis

  2009cited by this paper
• Methyl beta-cyclodextrin reduces accumulation of reactive oxygen species and cell death in yeast.

  2009cited by this paper
• Formulation of rifampicin-cyclodextrin complexes for lung nebulization.

  2008cited by this paper
• Electrochemiluminescence from successive electro- and chemo-oxidation of rifampicin and its application to the determination of rifampicin in pharmaceutical preparations and human urine.

  2007cited by this paper
• The influence of pH and anions on the adsorption mechanism of rifampicin on silver colloids

  2007cited by this paper
• Cyclodextrins in drug delivery: An updated review

  2005cited by this paper
• Rifamycin-mode of action, resistance, and biosynthesis.

  2005cited by this paper
• Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils

  2004cited by this paper
• Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils.

  2004cited by this paper
• Tear lipocalin: potential for selective delivery of rifampin.

  2004cited by this paper
• Análise da associação molecular da rifampicina com hidroxipropil-²-ciclodextrina

  2004cited by this paper
• Study of inclusion complexes of acridine with β‐ and (2,6‐di‐O‐methyl)‐β‐cyclodextrin by use of solubility diagrams and NMR spectroscopy

  2002cited by this paper
• A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem.

  2001cited by this paper
• Structural mechanism for rifampicin inhibition of bacterial rna polymerase.

  2001cited by this paper
• Heavy metal stabilization in municipal solid waste combustion bottom ash using soluble phosphate

  2000cited by this paper
• Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part IV: phosphate buffer dependence

  1999cited by this paper
• Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development.

  1999cited by this paper
• Stability of rifampicin in dissolution medium in presence of isoniazid.

  1999cited by this paper
• The Effects of Different Buffers on the Oxidation of DNA by Thiols and Ferric Iron

  1998cited by this paper
• Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

  1996cited by this paper
• Rifampicin loading of vascular grafts.

  1996cited by this paper
• Kinetics for degradation of rifampicin, an azomethine-containing drug which exhibits reversible hydrolysis in acidic solutions

  1992cited by this paper
• Oxidation of low-density lipoprotein by copper and iron in phosphate buffer.

  1991cited by this paper
• Oxidation of low-density lipoprotein by copper and iron in phosphate buffer.

  1991cited by this paper
• Interaction of bovine seminalplasmin with Escherichia coli RNA polymerase in the presence of rifampicin

  1985cited by this paper
• Adverse effects of rifampin.

  1983cited by this paper
• Electronic transitions in 1,4-naphthoquinone derivatives☆

  1979cited by this paper

• Polar components in biochar boost oxygen vacancies and electron transfer for enhancing the degradation of tetracycline.

  2025cites this paper
• Formulation of Topical Drug Delivery Systems Containing a Fixed-Dose Isoniazid–Rifampicin Combination Using the Self-Emulsification Mechanism

  2025cites this paper
• Tailoring 2-oxazoline based digradient copolymers for rifampicin delivery: Synthesis, physicochemical properties, and colloidal behavior

  2025cites this paper
• Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion: an in-vitro and ex-vivo investigation

  2024cites this paper
• A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis

  2022cites this paper
• Dual Drug Loaded pH-sensitive Micelles for Efficient Bacterial Infection Treatment

  2022cites this paper
• Assessment of persistent antimicrobial and anti-biofilm activity of p-HEMA hydrogel loaded with rifampicin and cefixime

  2022cites this paper
• Innovative drug delivery systems for leprosy treatment.

  2022cites this paper
• Preparation and Spectroscopic Characterization of Inclusion Complexes of 3D Ball-Milled Rifampicin with β-cyclodextrin and γ-cyclodextrin

  2022cites this paper
• Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis

  2021cites this paper
• Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes

  2021cites this paper
• Multifunctional antibiotic- and zinc-containing mesoporous bioactive glass scaffolds to fight bone infection.

  2020cites this paper
• Antibiotic-in-cyclodextrin-in-liposomes: formulation development and interactions with model bacterial membranes.

  2020cites this paper
• Improved Activity of Rifampicin Against Biofilms of Staphylococcus aureus by Multicomponent Complexation

  2020cites this paper
• Increased antibiotic efficacy and noninvasive monitoring of Staphylococcus epidermidis biofilms using per-cysteamine-substituted γ-cyclodextrin-a delivery effect validated by fluorescence microscopy.

  2020cites this paper
• Enhancing Water Solubility and Stability of Natamycin by Molecular Encapsulation in Methyl-β-Cyclodextrin and its Mechanisms by Molecular Dynamics Simulations

  2019cites this paper
• Ionic liquid vortex-simplified matrix solid-phase dispersion for the simultaneous determination of terpenoids, crocins, quinic acid derivatives and flavonoids in Gardeniae fructus by UHPLC.

  2019cites this paper
• Ultrafast dynamics of the antibiotic Rifampicin in solution

  2019cites this paper
• Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities.

  2018cites this paper
• Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae

  2018cites this paper